Aikenhead Centre for Medical Discovery
The Aikenhead Centre for Medical Discovery – A hub fusing medicine, engineering, science and industry to yield significant economic, patient and healthcare impact, unlike anywhere else in Australia
The development of new treatments and medical solutions requires a diverse range of expertise, skill-sets, and environments that are not typically housed within a single organization.
The Aikenhead Centre for Medical Discovery (ACMD) is an ambitious initiative to create the first hospital-based, world-class health-tech innovation hub in Australia.
The ACMD is modeled after several best-of-breed international collaborative consortiums and hubs that have been demonstrated to accelerate the development of medical solutions to market and adoption in clinical practice thereby delivering better patient outcomes and quality of life.
Headquartered at St Vincent’s Hospital in the heart of Melbourne, the ACMD facility will be a purposefully designed landmark that stimulates connectivity and up-skilling of our best scientists, engineers, clinicians, allied health, and industry professionals to transform ground-breaking biomedical research and technologies into new medical solutions – effectively enabling more of the “development” in research and development (R&D).
Ms Shanahan has a longstanding background in Australian and overseas economies and share markets and is a Fellow of the Institute of Directors. She is currently a non-executive Director of Phoslock Ltd, Clinuvel Pharmaceuticals Ltd, Bell Financial Group Ltd and DMP Asset Management Ltd, and a Director of the Kimberley Foundation of Australia and the SVI Foundation. She has recently been appointed as a member of Swinburne University's Inaugural Research Advisory Committee. Brenda is also a former member of the Australian Stock Exchange and Chair of St. Vincent's Health Melbourne Ltd and St. Vincent's Medical Research Institute, and Director of St. Vincent's Health Australia.
Brenda Shanahan, Chair